Latest News Archive
Please select Category, Year, and then Month to display items
10 July 2018
Photo Supplied
The Kovsie men’s and women’s hockey teams have positive expectations for the University Sport South Africa (USSA) national student tournament.
The USSA championships were hosted by the University of the Free State (UFS) from 2 to 6 July 2018. This year’s championships will have 45 competing teams and will thus be the biggest ever USSA hockey tournament.
For the female squad to qualify for the 2019 Varsity Sports tournament, they have to secure a spot among the top-seven teams. In order to get back into the A section, the Kovsie men’s team must win their tournament.
The matches are scheduled to take place on the UFS Bloemfontein Campus astro fields.
The UFS women’s team, captained by Antonet Louw, is set to play on Monday at 15:35 against Nelson Mandela University (NMU); on Tuesday at 17:00 against the University of Johannesburg (UJ); and on Wednesday at 18:25 against North-West University (NWU). The play-off matches will take place on Wednesday, Thursday, and Friday.
The men’s team, with Cheslyn Neethling as captain, will play on Monday at 17:00 against the Central University of Technology; on Tuesday at 15:35 against the Tswane University of Technology; on Wednesday at 17:00 against the Vaal University of Technology; on Thursday at 18:25 against the University of KwaZulu-Natal; and on Friday at 15:35 against Rhodes University.
New research informs improved treatment of brain inflammation
2017-10-13
Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish
Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology.
Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.
Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs.
Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology